Blood Biomarker More Accurately Predicts Lung Cancer Immunotherapy Response than Tumor Biopsy
A simple blood test could be an ideal predictor of whether cancer immunotherapy will be successful for a lung cancer patient.
Read MorePosted by Andy Lundin | Jun 6, 2022 | Lung Cancer |
A simple blood test could be an ideal predictor of whether cancer immunotherapy will be successful for a lung cancer patient.
Read MorePosted by Chris Wolski | May 26, 2022 | Cancer |
Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients.
Read MorePosted by Chris Wolski | May 11, 2022 | Lab Management |
Laboratory leadership needs to develop coherent succession planning to allow for the continuity of laboratory operations.
Read MorePosted by Andy Lundin | May 6, 2022 | Hematology & Serology, Molecular Diagnostics |
Researchers have developed an approach to identify blood biomarkers that could predict the suicide risk of major depressive disorder patients.
Read MorePosted by Chris Wolski | May 4, 2022 | Immunoassay Reagents & test Kits |
HORIBA Medical announces that its novel hemostatic D-dimer immunoassay, Yumizen G DDi 2, has been independently validated.
Read More